Zobrazeno 51 - 60
of 110
pro vyhledávání: '"59"'
Publikováno v:
Transplantation. 77:1692-1698
Background. The human cytomegalovirus (CMV) is a major cause of morbidity and mortality in transplant patients. In this study, we compared the diagnostic value of pp65 antigen test, qualitative nested polymerase chain reaction (PCR), and quantitative
Publikováno v:
Transplantation. 70:606-612
Background. It is well established that repeat heart transplantation has a significantly worse outcome when compared with primary (first time) transplantation. Defining the risk factors for mortality within this group has been difficult due to small
Publikováno v:
Transplantation. 67:69-72
Background The quality of life, psychologic sequelae, and functional status of liver transplant recipients with recurrent hepatitis C virus (HCV) hepatitis have not been well defined. Methods. Perceived quality of life, psychologic distress, depressi
Autor:
John H. Gordon, D A Laskow, John F. Neylan, Richard B. Freeman, Flavio Vincenti, J. Richard Thistlethwaite, E. Steve Woodle, Robert Mendez, Saleh Aswad, James F. Burdick, Frank L. Delmonico, Alan H. Wilkinson, Russell H. Wiesner, Beth Schwartz, Stephen R. Munn, Lewis Burrows, Gabriel M. Danovitch, David Williamson Shaffer, Hans W. Sollinger, John D. Pirsch, Richard J. Rohrer, Mark H. Deierhoi, Mary Ann Simpson, J. Whelchel
Publikováno v:
ResearcherID
A multicenter trial was conducted to evaluate the efficacy and safety of tacrolimus in the treatment of refractory renal allograft rejection. Renal transplant recipients experiencing biopsy-proven recurrent acute allograft rejection were eligible if
Publikováno v:
Transplantation. 61:1695-1699
Episodes of acute rejection seem to play an important role in the development of chronic allograft failure. Whereas acute rejection appears to be fully reversible, at least at early stages, reversibility of chronic graft alterations is still unclear.
Publikováno v:
Europe PubMed Central
Liver allograft rejection is usually divided into acute (cellular) rejection and chronic (ductopenic) rejection. Most cases of acute rejection occur within four weeks of transplantation. There is a paucity of published literature on late acute reject
Autor:
Donna Phelan, T. Mohanakumar, Samuel So, Martin D. Jendrisak, Tina M. Rush, Sheila M. Michalski, Douglas W. Hanto, Christopher S. McCullough
Publikováno v:
Transplantation. 57:377-384
Improved cadaver kidney allograft survival rates, shorter duration of acute tubular necrosis, and a reduction in the incidence of rejection have been achieved using "quadruple sequential therapy"--AZA, prednisone, and antilymphocyte globulin (ALG) in
Autor:
Adam Gondos, Hermann Brenner
Publikováno v:
Transplantation. 92(8)
Background Relative survival estimates, used in population-based monitoring of survival of patients with cancer, accounts for differences in the background mortality (obtained from general population life tables) of patient populations to improve the
Autor:
Francisco, Ortega, Ana, Sánchez-Fructuoso, José María, Cruzado, Juan Carlos, Gómez-Alamillo, Antonio, Alarcón, Lluís, Pallardó, José María, Morales, Juan, Oliver, Guillermo, Guinea, A, Sánchez-Fructuoso
Publikováno v:
Transplantation. 92(4)
Background In renal transplant (RT) recipients, treatment with enteric-coated mycophenolate sodium (EC-MPS) improves gastrointestinal (GI) tolerability compared with mycophenolate mofetil (MMF). The impact of conversion from MMF to EC-MPS on patient'
Publikováno v:
Transplantation. 91(12)
Background. Improved early kidney transplant outcomes limit the contemporary utility of standard clinical endpoints. Quantifying the relationship of renal function at 1 year after transplant with subsequent clinical outcomes and healthcare costs may